27 C
Vientiane
Tuesday, April 29, 2025
spot_img
Home Blog Page 581

Hankyung.com introduces: CODIT Launches AI-Powered English Policy Dashboard to Help Global Companies Track Korean Regulatory Changes

New platform provides real-time updates on Korean legislation and policy shifts for government affairs and legal teams

SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ — A news report from Hankyung.com:

CODIT, an AI-driven regulatory intelligence platform, has launched an English-language policy dashboard designed to help multinational corporations track legislative and regulatory changes in South Korea in real time. The platform aims to support government affairs professionals, legal teams, and compliance officers by providing instant updates on policy shifts, enforcement trends, and legislative developments affecting foreign businesses.

CODIT Launches AI-Powered English Policy Dashboard to Help Global Companies Track Korean Regulatory Changes
CODIT Launches AI-Powered English Policy Dashboard to Help Global Companies Track Korean Regulatory Changes

The English Policy Dashboard is the first AI-powered platform of its kind to offer automated translation, legislative tracking, and policy risk assessment for global companies operating in Korea. With increasing regulatory scrutiny in areas such as artificial intelligence, ESG disclosure, and foreign investment, CODIT’s solution is designed to help companies proactively manage compliance risks and align corporate strategy with evolving regulations.

Korea’s regulatory environment is shifting rapidly, and global companies need more than delayed translations or fragmented updates,” said Ji Eun Chung, CEO of CODIT and a former OECD policy expert. “Our AI-powered dashboard delivers real-time intelligence, giving legal and government affairs teams the ability to anticipate changes, mitigate risks, and make strategic decisions with confidence.

AI-Powered Monitoring for Legislative and Compliance Teams

CODIT’s English Policy Dashboard includes several key features designed to streamline regulatory monitoring for multinational businesses:

  • Legislative Tracking: Real-time updates on proposed, pending, and enacted laws impacting corporate governance, AI regulation, ESG compliance, and digital policy.
  • AI-Powered Policy Insights: Automated translation and expert analysis of government regulations, policy trends, and enforcement actions.
  • Regulatory Risk Monitoring: A ranked list of Fair Trade Commission penalties, tracking top regulatory fines with live currency adjustments.
  • Government Press Releases & Statements: Translations of official announcements, policy updates, and legislative briefings for global accessibility.

CODIT’s launch comes as global businesses increasingly seek more efficient tools to navigate Korea’s policy landscape, particularly in highly regulated industries such as finance, technology, and pharmaceuticals.

Regulatory uncertainty is one of the biggest challenges for companies entering or expanding in Korea,” said Chung. “By leveraging AI, we’re making it easier for multinational corporations to stay ahead of policy changes and regulatory trends that could impact their operations.

Global Business Leaders Join CODIT’s Policy Webinar

Ahead of the launch, nearly 200 business leaders from Korea, Japan, the United States, Germany, and Singapore participated in CODIT’s policy webinar, “Navigating Korea’s 2025 Policy & Regulatory Landscape.” The event featured Hong Ihk-pyo, a three-term National Assembly member and former Floor Leader of Korea’s largest political party, discussing key regulatory shifts in 2025. CODIT CEO Ji Eun Chung provided a comparative analysis of Korea’s regulatory direction against key markets, including the U.S. and Asia, offering insights for multinational corporations navigating compliance and market risks.

Expansion to U.S. and International Markets

The launch of the English Policy Dashboard is part of CODIT’s broader global expansion strategy, with plans to enter the United States, Japan, and the European Union in 2025. CODIT, already trusted by Fortune 500 companies, is building out its AI-powered regulatory intelligence platform to offer policy tracking solutions across multiple jurisdictions.

As regulatory complexity increases worldwide, companies must take a more proactive approach to compliance and policy monitoring,” Chung said. “We are scaling our AI-driven intelligence platform to provide businesses with real-time, cross-border policy insights.

Availability

The English Policy Dashboard is now live and available to global enterprises. Companies seeking AI-powered policy tracking and compliance solutions can learn more at www.thecodit.com.

Ricoh Releases “The Business Guide to Print Technologies” – A Data-Driven Analysis of Print’s Role in the Modern Workplace

New whitepaper presents independent research on print performance, sustainability, and security, helping businesses optimise their workplace technology

TOKYO, Feb. 13, 2025 /PRNewswire/ — Ricoh Asia Pacific today announced the release of The Business Guide to Print Technologies, a comprehensive whitepaper based on independent, real-world testing of laser and inkjet print technologies.

Developed in collaboration with DataMaster Labs, a leading independent print technology research firm specialising in laboratory-based performance evaluation, the study provides evidence-backed insights into how print impacts productivity, operational costs, and sustainability.

As organisations continue to digitise workflows and embrace hybrid work models, print remains a critical component of information management, security, and operational efficiency. This whitepaper helps businesses make informed decisions about the technologies that best support their evolving needs.

“With hybrid work and digital transformation accelerating, businesses need print solutions that integrate seamlessly with their workflows rather than disrupt them,” said Steven Burger, Vice President APAC Technology Centre at Ricoh Asia Pacific. “This whitepaper cuts through marketing claims to provide businesses with the objective data they need to optimise their print strategies.”

Key Findings from the Whitepaper:

  • Laser vs. Inkjet: The Performance Gap – In high-demand environments, laser printers maintained 97% of their rated speed, while inkjet speeds dropped by up to 141% when handling complex print jobs.
  • Print Quality and Business Impact – Independent testing rated laser print output 91/100, compared to 76/100 for inkjet, particularly for sharp text reproduction and colour consistency.
  • Sustainability and Cost Efficiency – A Ricoh laser printer in standby mode consumes just 0.32W—one-third the energy of comparable inkjet models. Additionally, toner-based prints are easier to recycle, reducing environmental impact.
  • Security and Integration – Laser print technology integrates more effectively with enterprise security frameworks and digital workflows, minimising bottlenecks and data security risks in high-volume environments.

The findings in The Business Guide to Print Technologies whitepaper reinforce Ricoh’s vision of print as a key enabler of workplace transformation. These themes will also be explored at SPARK, Ricoh’s new annual leadership event in Thailand, where industry experts will examine how hybrid workplace solutions, workflow automation, cloud and IT, cybersecurity, and managed print intersect to create smarter, more secure, and more efficient business environments—shaping the future of work.

“Organisations that recognise print as a crucial part of their information ecosystem—rather than just a standalone function—are better positioned for efficiency, security, and long-term success,” added Steven Burger. “By enabling the seamless transfer of data between physical and digital workflows, Ricoh is helping businesses create smarter, more connected workplaces where information flows effortlessly and securely.”

Download the Whitepaper

“The Business Guide to Print Technologies” is available for download now at  The Business Guide to Print Technologies

-Ends-

About Ricoh

Ricoh is a leading provider of integrated digital services and print and imaging solutions designed to support the digital transformation of workplaces, workspaces and optimise business performance.

Headquartered in Tokyo, Ricoh’s global operation reaches customers in approximately 200 countries and regions, supported by cultivated knowledge, technologies, and organisational capabilities nurtured over its 85-year history. In the financial year ended March 2024, Ricoh Group had worldwide sales of 2,348 billion yen (approx. 15.5 billion USD).

It is Ricoh’s mission and vision to empower individuals to find ‘Fulfillment through Work’ by understanding and transforming how people work so we can unleash their potential and creativity to realise a sustainable future.

For further information, please visit www.ricoh.com

© 2025 RICOH ASIA PACIFIC PTE LTD. All rights reserved. All referenced product names are the trademarks of their respective companies.

Finmo Secures US$18.5 Million To Revolutionize Treasury Management

  • Oversubscribed Series A Funding Round Was Co-Led By Quona Capital and PayPal Ventures with Participation from Citi Ventures
  • Finmo Will Use Funds to Accelerate Product Development and AI Capabilities and Expand Global Reach

SINGAPORE, Feb. 13, 2025 /PRNewswire/ — Finmo, the pioneering all-in-one Treasury Operating System (TOS), today announced its successful oversubscribed $18.5 Million Series A funding round, bringing its total funding to US$27 million. This investment underscores the growing demand for an innovative approach to modern treasury management. With the new funding, Finmo plans to accelerate its product development, invest in AI capabilities, and expand its global reach. The company aims to continue delivering cutting-edge solutions that not only improve operational efficiency but also empower organizations to make informed financial decisions by better harnessing the power of its treasury operating system.

Finmo founders (from left to right): Thomas Kang, Chief Revenue Officer; Akhil Nigam, Chief Product Officer; David Hanna, Chief Executive Officer; Raj Vimal Chopra, Chief Technology Officer; Richard Oh, Chief Strategy Officer.
Finmo founders (from left to right): Thomas Kang, Chief Revenue Officer; Akhil Nigam, Chief Product Officer; David Hanna, Chief Executive Officer; Raj Vimal Chopra, Chief Technology Officer; Richard Oh, Chief Strategy Officer.

The funding round was co-led by prominent investors Quona Capital and PayPal Ventures with participation from Citi Ventures. Known for their investment focus on cutting-edge fintech companies, these investors’ support is a strong validation of Finmo’s value proposition. Finmo offers a unified platform that addresses the complexities of modern treasury operations.

The Finmo TOS is uniquely designed to address the need for effective treasury management in a global context. It streamlines payment processes, enhances cash flow visibility, manages FX risks, ensures compliance, automates manual tasks, and optimizes financial decision-making, including excess liquidity management. With features such as real-time payment capabilities, modular design for scalability, and a strong emphasis on regulatory compliance, Finmo empowers organizations to optimize their cash management, enhance liquidity, and mitigate financial risks—all within a single platform.

Today’s organizations are global players that demand integrated solutions to streamline their treasury functions. Finmo was developed with a first-hand understanding of what treasurers and CFOs need, ensuring that the platform addresses real-world challenges faced by finance professionals today.

“We are thrilled to have the support of esteemed investors such as PayPal Ventures, Quona, and Citi Ventures,” said David Hanna, CEO and Co-Founder of Finmo. “This funding validates our vision of transforming how global businesses manage their treasury function and enables us to scale our platform, enhance our technology further, and expand into new markets. Underpinning all these developments will be our continued commitment to focus on our customers’ evolving needs to enhance operational efficiency, risk mitigation, and strategic financial decision-making.”

Ashish Aggarwal, Partner at PayPal Ventures, said, “Finmo is redefining treasury operations. Their innovative approach addresses critical pain points faced by businesses in today’s dynamic financial landscape. We are proud to support their journey as they continue to deliver transformative solutions that empower organizations globally.”

“Finmo’s innovative Treasury Operating System addresses critical pain points for businesses operating in multiple geographies, empowering them with seamless cash and FX management capabilities,” said Ganesh Rengaswamy, Co-Founder and Managing Partner at Quona, which co-led the Series A. “With their exceptional founding team and strong financial discipline, we believe Finmo is well-positioned to redefine how businesses manage payments, liquidity and risk, and we are excited to support their vision to revolutionize treasury management and cross-border payments for businesses across APAC and beyond.”

About Finmo

Finmo is a global treasury operating system that empowers businesses to manage cross-border payments, optimize liquidity, and navigate financial complexities with ease. Founded in 2021, Finmo is committed to simplifying treasury operations for businesses of all sizes.

For more information about Finmo and its mission to redefine global treasury operations, visit www.finmo.net.

MGM China Reports 2024 Annual Results

Record-High Revenue and EBITDA

Market Share Continued to Grow

HONG KONG, Feb. 13, 2025 /PRNewswire/ — MGM China Holdings Limited (“MGM China” or the “Company”; SEHK Stock Code: 2282) today announced the selected unaudited financial data of the Company and its subsidiaries (the “Group”) for the three and 12 months ended December 31, 2024.

The Group is pleased to see Macau continuing to grow in 2024. The city welcomed 34.9 million visitors in 2024, up by 24% from a year ago. Daily visitation reached 95,433, represents a recovery of 88% of 2019 pre-COVID levels.

Gross gaming revenue (GGR) also grew in 2024. Industry GGR was up 24% year-on-year to MOP620 million per day in 2024, recovered to 77% of 2019.

  • MGM China continued to outperform industry recovery in 2024. Property visitation grew 54% year-on-year, reached 163% of 2019. Daily GGR was up 29% to 129% of 2019. Mass GGR (including slot) was up 33% to reach 179% of pre-COVID levels.
  • Net revenue of the Group grew by 27% to HK$31.4 billion in 2024, or 138% of 2019.
  • Adjusted EBITDA also reached historical high of HK$9.1 billion in 2024, up by 25% from a year ago, represented 147% of 2019.
  • MGM China saw market share at all-time high of 15.8% in 2024, up from 15.2% in 2023 and compared to 9.5% in 2019. MGM COTAI market share was 9.3% and MGM MACAU was 6.5%.
  • Adjusted EBITDA margin was 28.9% in 2024, 170 basis points higher than 2019, with a mass-focused business and continuous improvement in operational efficiency.
  • Hotel occupancy reached 94% in 2024, up from 92.5% in 2023.
  • The Group maintained a healthy financial position. As of December 31, 2024, the Group had a total liquidity of approximately HK$17.2 billion, comprised of cash, cash equivalents and undrawn revolver.

With a guest-centric focus, MGM is awarded during the Period seven Five-Star awards by Forbes Travel Guide 2024. It demonstrates our leading position in the hospitality industry and its commitment to providing the finest service and resort amenities.

During 2024, MGM China has proudly delivered a series of non-gaming events and excitements to Macau. We have hosted in January an outdoor concert with Bruno Mars, the 15-time Grammy Awards-winner. We had also presented with world-renowned musician Tan Dun his symphonic masterpiece Buddha Passion at the MGM Theater at MGM COTAI. In October to December, we celebrated the German beer festival with our annual mega event Oktoberfest Macau at MGM 2024; we also hosted MGM Chef Nic Gastronomusic Fest for the third year at MGM COTAI. The multi-sensorial cultural IP extravaganzas fully leverage on Macau as an interactive platform for diverse cultural exchange, which brings international gastronomy and musical culture to the city. These events also reinforce Macau’s golden calling cards as a “Creative City of Gastronomy” and “City of Performing Arts”.

As an advocate of cultural tourism, Poly MGM Museum opened at MGM MACAU in November 2024 in a collaboration with the Poly Culture Group. Spanning across nearly 2,000 square meters, the museum has been meticulously designed to meet national standards for exhibiting Grade-One cultural relics, blending traditional craftsmanship with cutting-edge technology to create an immersive experience for visitors. The inaugural exhibition, entitled The Maritime Silk Road – Discover the Mystical Seas and Encounter the Treasures of the Ancient Trade Route, features an array of 228 artifacts and artworks tracing the route’s rich history.

In the seemingly exciting December, MGM has joined hands with the renowned Chinese filmmaker Zhang Yimou to present a groundbreaking residency show – Macau 2049 at the MGM Theater. The unparallel show transcends time and space while bridging culture of the east and the west, through the celebration of Chinese performance arts.

Kenneth Feng, President and Executive Director of MGM China said: “We are exhilarated to have nearly 500,000 visitors to date to our Poly MGM Museum, and a ticket sale of over 42,000 for Macau 2049. Through the offering of these one-of-the-kind IP experiences, we are dedicated to drive non-gaming revenues and visitation to Macau, promoting cultural tourism and economic diversification.”

Outside our properties, MGM China goes beyond leveraging our cultural tourism strengths and joins effort to revitalize local district in Macau. The Group has introduced a series of art exhibitions, workshops, retails and leisure activities in the world heritage A-Ma Temple area to enhance community engagement efforts in the Barra district, driving the area’s future development.

Kenneth Feng said: “We are delighted to see the recovery in Macau, along with the diversification development of the city. We are committed to developing Macau into a global and diversified tourist destination through our concession commitments.”

About MGM China Holdings Limited

MGM China Holdings Limited (HKEx: 2282) is a leading developer, owner and operator of gaming and lodging resorts in the Greater China region. We are the holding company of MGM Grand Paradise, SA which holds one of the six gaming concessions to run casino games in Macau. MGM Grand Paradise, SA owns and operates MGM MACAU, the award-winning premium integrated resort located on the Macau Peninsula and MGM COTAI, a contemporary luxury integrated resort in Cotai, which opened in 2018 and more than doubles our presence in Macau. 

MGM China is majority owned by MGM Resorts International (NYSE: MGM) one of the world’s leading global hospitality companies, operating a portfolio of destination resort brands including Bellagio, ARIA, MGM Grand, Mandalay Bay and Park MGM. For more information about MGM Resorts International, visit the Company’s website at www.mgmresorts.com.

Japan’s Leading Crypto Tax Service, cryptact, Now Available in Canada – Trusted Reports from US$22.50

As Japan’s top crypto tax service, trusted by more than 150,000 users since 2017, cryptact is now available in Canada – offering reliable tax reports at a campaign price of US$22.50. Founded by former Goldman Sachs executives, cryptact brings institutional-grade expertise to simplify cryptocurrency tax filing with accuracy and efficiency.

TORONTO, Feb. 13, 2025 /PRNewswire/ — pafin Inc. (Co-CEOs Amin Azmoudeh and Gaku Saito), the provider of cryptact, a leading cryptocurrency calculation service for tax filing, today announced its official launch in Canada. Founded by former Goldman Sachs executives with extensive experience in finance and investment, cryptact leverages institutional-level expertise to deliver accurate and efficient crypto tax solutions.

cryptact_Crypto tax calculations: Simplified.
cryptact_Crypto tax calculations: Simplified.

To mark this milestone, cryptact is offering a 50% discount on paid plans until April 30, 2025.

Key Features of cryptact

  • Japan’s leading crypto tax service: since 2017, cryptact has been the most trusted crypto tax service in Japan, serving more than 150,000 users. Developed by a multicultural startup based in Tokyo, it is built by a team of experts in finance, technology, and blockchain.
  • Wide support for exchanges and coins: cryptact supports 24,000+ cryptocurrencies across 137 exchanges and blockchains, offering one of the broadest coverages among crypto tax service providers.
  • Comprehensive free access: users can start calculating capital gains, losses and income for exchanges, DeFi, and NFTs, and import up to 100,000 transactions per year – all for free.
  • The most affordable tax reports: with a 50% discount, “Basic” plan, normally priced at US$45, is now available for just US$22.50 – offering one of the best values among crypto tax service providers.
  • All past tax years covered: by purchasing an annual subscription, users can calculate profit and loss for any year, making it an accessible option for those filing a tax return for the first time.
  • Accurate and reliable calculations: developed in collaboration with MetaCounts, a Canadian crypto tax expert, cryptact provides precise calculations for a wide range of transaction types.
  • Automatic identification of DeFi and NFT transaction types: users can simply input a wallet address, and cryptact will automatically import all transaction history and identify transaction types, significantly reducing manual work.
  • Seamless transition from other services: no past transaction history is required. Users can get started by entering only the cryptocurrencies held as of January 1st of the tax year and their cost basis.

Service page: start using our services for free with just your email address.

https://www.cryptact.com/en

About the Canada Launch Campaign

  • Eligible Users: Residents of Canada
  • Offer: 50% off on new purchases or plan upgrades for all plans (excluding the Data Retention Plan)
  • How to Apply the Discount: No coupon code required – simply sign up via the service page above, and the discount will be automatically applied at checkout.
  • Offer Period: February 12, 2025April 30, 2025, 23:59 EDT

Future Outlook

“We are committed to continuously improving our services to meet the evolving needs of our users. As a trusted partner for cryptocurrency users in Canada, we will expand support for additional cryptocurrencies, exchanges, and blockchains while introducing new features to further enhance our user experience.” said Amin Azmoudeh, Co-CEO, pafin Inc.

Leadership Profiles

cryptact founder: Amin / Gaku
cryptact founder: Amin / Gaku

Amin Azmoudeh, Co-CEO

After graduating with a BS in Computer Science and a BA in Japanese from the University of Maryland in 2003, Amin joined Goldman Sachs Tokyo as the sole technologist of Tokyo’s GSPS team, a principal strategies unit managing the firm’s capital. In 2005, he changed careers to become a financial analyst with GSPS, and in 2007, he transferred to GSIP (Goldman Sachs Investment Partners) as part of the spin-out of the team into GSAM. As a financial/analyst and portfolio manager, Amin managed listed/unlisted equities, bonds, swaps, interest rate products, foreign exchange, derivatives as well as overall risk management. He was promoted to Managing Director in 2013 and retired from Goldman Sachs on December 31, 2017, to found cryptact.

Gaku Saito, Co-CEO

Having completed a Bachelor’s degree in System Innovation Engineering in 2005 and a Master’s degree in Environmental & Ocean Engineering in 2007 from The University of Tokyo, Gaku joined Goldman Sachs – Asia Special Situations Group, where he executed investments exceeding US$500 million in non-performing and sub-performing loan portfolios, private equity, real estate portfolios, and vessel portfolios. Also, he participated in a number of sponsorship auctions on bankrupt real estate developers. From May 2010 to January 2019, he worked at Goldman Sachs Investment Partners Worked as a portfolio manager at a multi-asset hedge fund, managing an US$800 million portfolio. His main investment strategy was equity long/short in listed companies based on a fundamental approach to building financial models. He also invested in equity derivatives, bond/CDS, FX, and mezzanine loan products. Since February 2019, he has been serving as Co-CEO of cryptact, and in 2021, he was appointed as Chairman of the JCBA Tax Review Department.

About the Team

Cryptact is developed and operated by a diverse, multinational team. With expertise in finance, technology and blockchain, the team brings a global perspective to deliver a trusted and efficient crypto tax service.

https://www.pafin.com/en#team

About pafin Inc.

Services

Cryptact – Crypto tax calculations: Simplified –

Automatically calculate capital gains, access all the information you need for tax filing, and efficiently manage your portfolio — all in one place. Trusted by over 150,000 active users.

https://www.cryptact.com/en

X account: https://x.com/CryptactGlobal

defitact – Your Web3 Sidekick –

defitact allows you visualize, analyze and manage your DeFi assets, NFTs and transactions through a highly intuitive and interactive interface. All features are for free.

https://www.defitact.com/

Company Name: pafin Inc.
Date Founded: January 2018
Rep. Directors: Amin Azmoudeh, Co-CEO / Gaku Saito, Co-CEO
Equity: 1,364M JPY (Including reserve)
Location: Kojimachi HF Building 5F, Kojimachi 3-2-4, Chiyoda City, Tokyo, Japan 102-0083

Contact for public relations and media/press coverage-related inquiries 
pr@pafin.com 

Sequential and AMILI Secure Prestigious $1.8M UK-Singapore Collaborative R&D Project to Advance Gut-Skin Microbiome Science

LONDON, Feb. 13, 2025 /PRNewswire/ — Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, are proud to announce that they have been awarded the prestigious UK-Singapore Collaborative R&D Grant. The $1.8 million project, supported by Innovate UK and Enterprise SG, will make significant strides in characterising the interplay between the skin and gut microbiome, offering a groundbreaking approach to evaluating inflammatory skin disorders (ISDs) such as atopic dermatitis and psoriasis.

Sequential and AMILI Announce Strategic Partnership
Sequential and AMILI Announce Strategic Partnership

Chronic and recurrent ISDs affect 20-25% of the population, significantly impacting physical and mental well-being. Research has shown that the skin microbiome plays a crucial role in disease progression, with imbalances in the gut microbiota contributing extensively to ISD development. However, current microbiome testing services analyze the skin in isolation, failing to leverage the gut-skin axis for a comprehensive understanding of skin health.

Sequential has built a database of over 25,000 clinical skin microbiome samples and has pioneered the world’s early skin microbiome at-home tests that were made commercially available in 2019. The previous recipient of an Innovate UK Smart Grant, with labs in US, Europe and Asia, Sequential is currently working with over 80 personal care and pharmaceutical companies innovating in the skin microbiome field. 

AMILI, headquartered in Singapore, has been at the forefront of gut microbiome research. Since AMILI founders performed the first gut microbiome transplants in the region in 2014, AMILI has focused on developing and deeply analysing Asia’s largest multi-ethnic gut microbiome database to map the relationships and mechanistic pathways between changes in the gut microbiome and health conditions.

This funding allows both organizations to accelerate their efforts in developing targeted, microbiome-driven interventions.

“We are thrilled to have won this competitive grant, which will enable us to pioneer a novel approach to further characterise inflammatory skin conditions,” said Dr. Oliver Worsley, CEO of Sequential. “By leveraging our world-class skin microbiome dataset alongside AMILI’s extensive gut microbiome research, we will be able to have a real impact by developing next generation, actionable and non-invasive at-home tests.”

“We thank both our countries for the faith in us. The gut-skin axis is a novel but clearly important dimension to improve diagnostic testing for the millions around the world afflicted with ISD and we in AMILI are delighted to work with Sequential on this exciting project” said Dr. Jeremy Lim, CEO of AMILI.

 

Illuccix® Approved in the United Kingdom

MELBOURNE, Australia, Feb. 13, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the Marketing Authorization Application (MAA) for its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection).

Illuccix is indicated in the UK for the detection and localization of prostate-specific membrane antigen (PSMA)-positive lesions in adults with prostate cancer, using PET. PSMA-PET imaging[2] represents a major advancement in prostate cancer management, largely replacing conventional imaging methods (bone scan, CT[3] scan) as the standard of care after initial diagnosis and biochemical recurrence (BCR). Global guidelines highlight the superior accuracy of PSMA-PET for the staging of primary disease and evaluation of BCR/biochemical persistence (BCP)[4].

Gary Cook, MD, Professor of Molecular Imaging at Kings College London School of Biomedical Engineering & Imaging Sciences, commented, “PSMA-PET supply shortages in the UK and Europe have escalated over the past 12 months as demand increases, which has led to delays for men in urgent need of a scan to direct clinical management. It is great news that Telix can now help address this unmet need and improve equity of access in the UK through their Illuccix imaging agent and network distribution model.”

Raphaël Ortiz, Chief Executive Officer, Telix International added, “PSMA-PET imaging is one of the most important developments in prostate cancer detection in recent years and we are delighted that we can now bring Illuccix to physicians and their patients across the UK. A key advantage of Illuccix is that the radioisotope (gallium-68) can be produced using a generator locally, taking just a few minutes with minimal equipment. Reliable service delivery combined with greater scheduling flexibility, including in non-metropolitan locations, will benefit patients, physicians and clinical sites in the UK.”

Illuccix will be made available in the UK through Telix’s exclusive distribution partner, Xiel Limited, a specialist distributor of nuclear medicine, radiotherapy and diagnostic radiology technologies across the UK and Ireland. To order or enquire about Illuccix availability, UK healthcare professionals can email: radiopharm@xiel.co.uk or call +44 (0)1749 372217.

About Illuccix®  

Telix’s prostate imaging product, gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[5], by the Australian Therapeutic Goods Administration (TGA)[6], by Health Canada[7], by the Danish Medicines Agency[8], and by the UK MHRA. Illuccix is currently in national approval review in 19 European countries following a positive decentralized procedure (DCP) opinion by BfArM[9].

About Telix Pharmaceuticals Limited

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia, with international operations in the United States, Canada, Europe (Belgium and Switzerland), and Japan. Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. ARTMS, IsoTherapeutics, Lightpoint, Optimal Tracers and RLS are Telix Group companies. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX).

Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99mTc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix’s miniaturized surgical gamma probe, SENSEI®, for minimally invasive and robotic-assisted surgery, is registered with the FDA for use in the U.S. and has attained a Conformité Européenne (CE) Mark for use in the European Economic Area. No other Telix product has received a marketing authorization in any jurisdiction.

Visit www.telixpharma.com for further information about Telix, including details of the latest share price, ASX and SEC filings, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on LinkedInX and Facebook.

Telix Investor Relations

Ms. Kyahn Williamson
Telix Pharmaceuticals Limited
SVP Investor Relations and Corporate Communications
Email: kyahn.williamson@telixpharma.com

This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board.

Legal Notices

You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website.

The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States. The information and opinions contained in this announcement are subject to change without notification.  To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement.

This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as “may”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “outlook”, “forecast” and “guidance”, or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix’s good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix’s business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix’s business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix’s preclinical and clinical trials, and Telix’s research and development programs; Telix’s ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix’s product candidates, manufacturing activities and product marketing activities; Telix’s sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix’s product candidates, if or when they have been approved; Telix’s ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix’s expenses, future revenues and capital requirements; Telix’s financial performance; developments relating to Telix’s competitors and industry; and the pricing and reimbursement of Telix’s product candidates, if and after they have been approved. Telix’s actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements.

©2025 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Telix Group company, and Telix product names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. Trademark registration status may vary from country to country.

[1] Positron emission tomography.

[2] Imaging of prostate-specific membrane antigen with positron emission tomography.

[3] Computed tomography.

[4] EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3.: https://uroweb.org/guidelines/prostate-cancer;  Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 2023: https://www.esmo.org/guidelines/guidelines-by-topic/esmo-clinical-practice-guidelines-genitourinary-cancers/clinical-practice-guidelines-prostate-cancer/eupdate-prostate-cancer-treatment-recommendations

[5] Telix ASX disclosure 20 December 2021.

[6] Telix ASX disclosure 2 November 2021.

[7] Telix ASX disclosure 14 October 2022.

[8] Telix media release 11 February 2025.

[9] The German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte). Telix ASX disclosure 17 January 2025.

 

BWT ALPINE FORMULA ONE TEAM PARTNERS WITH OAKBERRY

MIAMI, Feb. 13, 2025 /PRNewswire/ — BWT Alpine Formula One Team proudly announces a new partnership with OAKBERRY, the superfood brand, world-famous for organic and delicious Açaí bowls and smoothies.

BWT Alpine Formula One Team proudly announces a new partnership with OAKBERRY.
BWT Alpine Formula One Team proudly announces a new partnership with OAKBERRY.

OAKBERRY is leading the charge in the rapidly growing market with their vegan, gluten-free healthy and 100% organic OAKBERRY Açaí products, bringing the superfood to consumers around the world.

The partnership between BWT Alpine Formula One Team and OAKBERRY will promote healthy eating as together they bring the all-natural Açaí to the racetrack.

With over 800 stores in more than 45 countries, including Australia, the United States, Europe, Asia and Middle East, OAKBERRY will add a special Açaí bar to the Formula One Paddock in the BWT Alpine Formula One Team Motorhome at European Grands Prix. Team guests and personnel will be able to fuel up with goodness as they enjoy the healthy product while at the track.

OAKBERRY branding will also feature prominently on the team’s 2025 challenger, the A525, all 24 races of the season.

Oliver Oakes, Team Principal, BWT Alpine Formula One Team:
“We are very excited to team up with OAKBERRY for the upcoming Formula One season. Our guests and team members will be treated to a healthy and authentic Açaí experience as they bring the superfood to BWT Alpine Formula One Team. The shared dynamic culture between fans of OAKBERRY and Formula One make this partnership hugely valuable.”

Georgios Frangulis, OAKBERRY Founder and CEO:
“We are very true to our legacy at OAKBERRY and I believe legacy is something that runs on Alpine Formula One DNA. With our global expansion strengthening yearly, it makes total sense for us to partner up with brands and platforms that can deliver the awareness we look for and most importantly, has its values aligned with ours.”

About OAKBERRY:
OAKBERRY was founded in Brazil in 2016 by Georgios Frangulis and Renato Haidar following a dream to create a quick-service superfood brand that is delicious, easy and fun to eat, and accessible to everyone. That dream became OAKBERRY’s refreshing and indulgent menu of açaí bowls and smoothies served up in visually appealing layers of açaí and customizable, unlimited toppings at shops worldwide. OAKBERRY’s açaí is sustainably sourced from Brazil’s Amazon Rainforest and is an abundant source of energy, rich in antioxidants, and organic with no high fructose corn syrup or artificial colors added.

A fast-growing brand with over 800 locations across more than 40 countries, OAKBERRY’S fully verticalized business model provides flexibility and operational efficiencies for its growing franchise model. To learn more about OAKBERRY, visit https://www.oakberry.com/en-us and follow along on social media at @oakberryusa; for franchise opportunities visit https://oakberryfranchise.com/.

About BWT Alpine Formula One Team:
BWT Alpine Formula One Team competes in the FIA Formula One World Championship with Grand Prix race winner Pierre Gasly and Formula 1 rookie Jack Doohan, under the leadership of Team Principal Oliver Oakes and Executive Advisor Flavio Briatore. The team, bought by the Benetton Family in 1986, was moved to Enstone, Oxfordshire, in 1992 where it is still based today. Renault bought the Italian-run team in 2000 and rebranded as Alpine F1. The team has a winning legacy, having won the Formula One World Championship seven times, including the Drivers’ World Championship (1994, 1995, 2005 and 2006) with Michael Schumacher and Fernando Alonso, and the Constructors’ World Championship (1995, 2005 and 2006). The team’s most recent triumph came at the 2021 Hungarian Grand Prix, the 50th victory overall. The team finished the 2024 season strongly with two podium finishes and ended the year sixth place overall in the Constructors’ Championship.

Media Contacts:
BWT Alpine Formula One Team: media@alpinef1.com
OAKBERRY: Haley Silvers haley.silvers@rfbinder.com